Harid Anad Explains What Sets Africure Pharmaceuticals Apart in Côte d’Ivoire’s Pharmaceutical Industry

In this section of the interview, Harid Anad explains the competitive advantages that set Africure Pharmaceuticals apart in Côte d’Ivoire’s pharmaceutical industry. One of the company’s greatest strengths is its manufacturing scale, with production capacity significantly exceeding that of other pharmaceutical plants operating in the country.

Another major advantage is Africure Pharmaceuticals’ ability to manufacture all three major dosage forms, tablets, capsules, and syrups, at significant scale. This diversified manufacturing capability gives the company a strong position in the local pharmaceutical market and enables it to address a broad range of healthcare needs.

Harid Anad also highlights the company’s extensive portfolio of approximately 80 licensed pharmaceutical products registered in Côte d’Ivoire. Given the country’s strict pharmaceutical regulatory requirements, which are aligned with World Health Organization standards, maintaining such a broad portfolio of approved medicines represents an important competitive advantage.

Affordability further differentiates Africure Pharmaceuticals. The company focuses on branded generic medicines rather than more expensive imported brands, allowing it to provide quality pharmaceutical products at prices accessible to patients across different income levels. Together, its large manufacturing capacity, diversified product portfolio, regulatory compliance, and focus on affordable medicines give Africure Pharmaceuticals a strong competitive position in Côte d’Ivoire’s pharmaceutical market.